Delivery Order SPE2DB22D2009-SPE2DB25FL8VD

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,060.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,815.46 firm-fixed-price delivery order contract is for the supply of the HIV medication Biktarvy, with a period of performance through May 14, 2025. The contract is not set aside and was awarded as part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,625.39, is a Firm Fixed Price Delivery Order for the provision of the drug Biktarvy, a medication used to treat HIV. The contract has an ultimate completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $17,986.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Biktarvy 50-200-25 mg tablets, a brand-name HIV medication. This is a Firm Fixed Price delivery order contract with a period of performance through May 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $6,776.75 Delivery Order contract is for the supply of the antiretroviral drug Biktarvy, a treatment for HIV/AIDS, to support military healthcare programs. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $7,175.27, is for the delivery of the HIV treatment medication Biktarvy. The contract is a Firm Fixed Price Delivery Order and does not have any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,644.48 firm fixed-price delivery order is for the supply of the prescription medication Biktarvy, a combination drug used to treat HIV. The contract has an ultimate completion date of April 22, 2025. This award is not associated with a set-aside program and represents open competition. AmerisourceBergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $41,322.09 and is a delivery order for the medication Biktarvy, a combination drug used to treat HIV. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $29,664.17 firm-fixed-price delivery order is for the supply of the HIV medication Biktarvy. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the Amerisourcebergen Corporation. The $13,719.72 Firm Fixed Price Delivery Order is for the supply of the prescription medication Biktarvy, a treatment for HIV. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL8VD
    Delivery Order

This federal contract award, valued at $19,773.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of the prescription medication Biktarvy, a treatment for human immunodeficiency virus (HIV). The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition.

Additionally, AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 7/15/25, 3:38 PM